Skip to main content

Table 5 Summary of vancomycin dose, estimated PK and PK-PD index parameters by baseline renal function

From: Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis

Parametersa

 

Normal renal

(>80 ml/min)

(n = 67)

Mild/moderate impairment

(30–80 ml/min)

(n = 53)

Severe impairment

(<30 ml/min)

(n = 13)

Daily dose (mg/kg/day)

Mean (CV%)

29.4 (36)

23.2 (39)

13.5 (58)

Median (range)

28.6 (9.3–60.4)

23.5 (8.2–53.0)

11.6 (4.0–35.3)

Clearance (CL, l/h)

Mean (CV%)

5.7 (44)

2.7 (38)

1.0 (47)

Median (range)

5.3 (0.8–11.3)

2.8 (0.9–4.9)

0.9 (0.3–2.0)

AUC0–24 (μg·h/ml)

Mean (CV%)

428 (38)

524 (33)

548 (22)

Median (range)

404 (153–1121)

484 (226–1203)

516 (384–777)

AUC0–24/MIC

Mean (CV%)

458 (58)

490 (41)

524 (26)

Median (range)

394 (76–1320)

472 (108–1203)

514 (309–777)

Trough concentration (Cmin, μg/ml)

Mean (CV%)

11.9 (54)

16.0 (40)

18.4 (25)

Median (range)

10.6 (3.2–38.6)

15.0 (6.7–42.5)

18.0 (12.4–28.7)

  1. CV% coefficient variation in percentage, AUC 0–24 area under the curve over 24 h, MIC minimum inhibitory concentration
  2. aThe average values during the treatment period in each individual were used for summary statistics